Quality in pharmacovigilance systems

Size: px
Start display at page:

Download "Quality in pharmacovigilance systems"

Transcription

1 Quality in pharmacovigilance systems June 20 th, 2014 Lisa Stagi, Medical Compliance Leader Roche Spa Quality systems in pharmacovigilance: legal requirements Regulation 1235/2010 e Directive 2010/84 Legal basis Regulation 520/2012 Minimum requirements for quality systems for carrying out the pharmacovigilance activities GVP Modulo I PV Systems and their Quality Systems 1

2 Quality systems in pharmacovigilance: legal requirements Consistency with principles in ISO standards ISO 9000 standard for quality management systems implementation defines: - How an organization manages process in a quality framework - How to manage compliance to defined requirements - How to manage customer satisfaction - A set to aim at continuous improvement (ISO 9004) What is quality and quality management system? 2

3 Definition of Quality Management Quality is: The degree to which a set of inherent characteristics fulfills requirements According to the ISO 9000 standard A Quality Management system is defined as: The organizational structure, responsibilities, procedures, processes and resources for implementing quality management According to US FDA 21 CFR 820 Definition of Quality Management System (QMS) Framework and mindset at same time It is a framework that sets out the structure, responsibilities and procedures that help us identify, measure, control and enhance core business processes The goal of a QMS is to maintain compliance and improve business performance. It is composed by different elements interconnected QMS is the difference between excellence and disaster 3

4 A mature GVP QMS includes 5 elements... Implemented both at a Global level and at Affiliate level Communication links between Global and local functions The cycle assures continuous improvement 7 QMS Framework Strategy & Governance Strategic direction and principles that demonstrates Roche s commitment to operate in a compliant way and is dedicated to continuous improvement Organisational Effectiveness Organisation that is structured in a clear way and is well resourced with people that are capable and trained to perform their activities Processes and Procedures Policies, SOPs, work instructions, processes and training materials that enables the business to be correctly skilled and compliant Records Objective evidence and associated network of IT systems, documentation and tools to collect, process, manage and store all data associated with GCP/GVP Continuous Improvement Process by which Roche continually improves the effectiveness of our procedures and overarching QMS 8 4

5 QMS Core Documents GCP/ GVP QMS Manual The fundamental document that summarises the content of the QMS framework Strategy & Governance Organisation Effectiveness Regular management reviews to assess Quality performance Clearly defined roles, job descriptions and training documented for all individuals GCP/ GVP Quality Plan Operational tool designed to oversee the implementation of the Quality Manual (updated annually) Processes & Procedures Record Continuous Improvement Standardized and simplified processes and SOPs across the organisation GVP documents stored in structured and easily accessible compliant systems Opportunities for improvement are identified through regular review of metrics & targets (KPI management and monitoring) 9 Strategy & Governan ce Regular management reviews to assess Quality System performance in order to provide management with adequate information Periodic assignment and review of quality objectives Governance model maps and charters 10 5

6 Organisatio n Effectivene ss Clearly defined roles, job descriptions and training documented for all individuals - QPPV with sufficient authority to affect the operation in the quality system and the activity of pharmacovigilance - organization chart and clear definition of roles and responsibilities (function in charge of PV system implementation and oversight, execution, audit activities) - job descriptions with description of main role responsibilities, including QPPV - defined procedures to be followed in case of emergency (back up) 11 Organisatio n Effectivene ss Clearly defined roles, job descriptions and training documented for all individuals - staff competent, qualified and trained, (documented way) including QPPV - initial and continuing training, documented - reliable and updated training records - Training efficacy 12 6

7 The marketing authorization holder has the responsibility to ensure that in relation to outsourced activities is applied to an effective system of quality Organisatio n Effectivene ss importance of procedures on vendors management and vendor continuous oversight, in order to assure a fully compliant system: - Pharmacovigilance agreements in place - KPI defined to have oversight of vendor activities - Audit plan 13 Process es & Procedu res Standardized and simplified processes and SOPs across the organization - continuous monitoring of pharmacovigilance data - Risk minimization and risk prevention, managing new risks or changes to existing risks - the scientific assessment of the risks of medicines - transmission to the EudraVigilance database of accurate and verifiable data on serious and non-serious adverse reactions, according to the timing defined by regulation - SOPs to guarantee the quality, integrity and completeness of the information provided on risks of medicines - To avoid double reporting - For validation of the signals 14 7

8 Standardized and simplified processes and SOPs across the organization Process es & Procedu res - effective communication with the competent Authorities - Business Continuity Plan - Managing the PSFM - Management of PSUR - Corrective and preventive actions - Post-authorization safety studies - the updating of product information - Safety management during clinical trials - Adequate provision of information relevant to safety to health professionals and patients 15 GCP / GVP documents are stored in structured and easily accessible compliant systems Record - Recording all the information of PV, handled and stored in such a way they can be reported, interpreted and verified thoroughly - Pharmacovigilance data and documents relating to individual medicines authorized preserved as required - Records management system for all documents used for pharmacovigilance activities in order to: Find these documents Track how and when were examined / made decisions on safety issues - Tracking and follow-up of adverse reaction reports - Keeping the elements of the PSFM according to law requirements 16 8

9 Continuous Improveme nt Opportunities for improvement are identified through regular review of metrics & targets (KPI management and monitoring) Periodic review of Quality Plans Implement Quality Monitoring ( routine sourvellaince of activities performed through Quality Control and Quality Assurance activities) 17 Quality Control activities Continuo us Improve ment - Double check activities and quality control plan for more relevant processes (IRT collection, RMP ) - Monitoring of process performance through KPI, regularly collected and reviewed -KPI identified based on the main attributes of processes (in terms of accuracy, consistency, completeness and medical adherence) dashboard developed to be considered by senior management. - KPI out of control subject to CAPA (Corrective & Preventative) management 18 9

10 Quality Assurance activities Continuo us Improve ment Audit - Periodic audits based on risk and process analysis, with a defined audit plan to ensure compliance with quality system requirements described to determine the effectiveness outsourced activities covered by audit plan - Audits carried out by people who do not have responsibility or implications Independent auditors required (Quality Assurance function) - Documented reports and follow up 19 Quality Assurance activities Continuo us Improve ment CAPA management - Defined SOPs to track, manage and periodically review corrective and preventative actions, to be reported to senior management in management review - Deviation management 20 10

11 Quality is not an act, it s a habit Aristotile Our approach to QMS Fully engrained quality in the organization Systems & Processes GxP Process Business Process Capabilities Skills Knowledge Experience Education Training Mindset Accountability Proactive Thinking Commitment Robust business processes & systems Process capability/ KPIs Leadership & business acumen Qualified Staff Compliance sustainability & proactive risk management Quality owned by all 11

12 Most importantly: Keep it Simple! 23 Grazie per l attenzione 12

Seminario SSFA. New Guideline on Good Pharmacovigilance Practice (GVP) Fare clic per modificare lo stile del sottotitolo dello schema

Seminario SSFA. New Guideline on Good Pharmacovigilance Practice (GVP) Fare clic per modificare lo stile del sottotitolo dello schema Seminario SSFA New Guideline on Good Pharmacovigilance Practice (GVP) Pharmacovigilance Systems and their Quality Systems Milano, 20th April 2012 GIULIA M. VALSECCHI The proposed GVP - Module 1 Guidance

More information

Guideline on good pharmacovigilance practices (GVP)

Guideline on good pharmacovigilance practices (GVP) 1 2 20 February 2012 EMA/541760/2011 3 4 Guideline on good pharmacovigilance practices (GVP) Module I Pharmacovigilance systems and their quality systems Draft finalised by the Agency in collaboration

More information

Guideline on good pharmacovigilance practices (GVP)

Guideline on good pharmacovigilance practices (GVP) 9 April 2013 EMA/816573/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module II Pharmacovigilance system master file (Rev 1) Draft of first version finalised by the Agency in collaboration

More information

Guideline on good pharmacovigilance practices (GVP)

Guideline on good pharmacovigilance practices (GVP) 22 June 2012 EMA/541760/2011 Guideline on good pharmacovigilance practices (GVP) Module I Pharmacovigilance systems and their quality systems Draft finalised by the Agency in collaboration with Member

More information

Detailed guidance AEs reporting in clinical trials ( CT-3 ) Stefano Bonato, M.D. Pharmacovigilance Country Head Bayer HealthCare Pharmaceuticals

Detailed guidance AEs reporting in clinical trials ( CT-3 ) Stefano Bonato, M.D. Pharmacovigilance Country Head Bayer HealthCare Pharmaceuticals Detailed guidance AEs reporting in clinical trials ( CT-3 ) Stefano Bonato, M.D. Pharmacovigilance Country Head Bayer HealthCare Pharmaceuticals Pharmacovigilance costs 0.12%-0.22% of hospital admissions

More information

Pharmacovigilance System Master File (PSMF), QPPV and audits

Pharmacovigilance System Master File (PSMF), QPPV and audits Federal Agency for Medicines and Health Products (FAMHP) Pharmacovigilance System Master File (PSMF), QPPV and audits Matthijs Nele, PhV Inspector, DG Inspection BRAS - FAMHP/NM/ 1 Content Introduction

More information

The Concept of Quality in Clinical Research. Dorota Śwituła Senior Clinical Quality Assurance Advisor

The Concept of Quality in Clinical Research. Dorota Śwituła Senior Clinical Quality Assurance Advisor The Concept of Quality in Clinical Research Dorota Śwituła Senior Clinical Quality Assurance Advisor 1 Agenda What is quality? How we define quality in clinical research? The standard components of a Quality

More information

Complacency is not an Option

Complacency is not an Option Complacency is not an Option Frank Deane, Ph.D., President, Global Manufacturing, Eli Lilly and Company 2 Agenda Lilly s manufacturing quality transformation journey Lilly s quality system Control strategy

More information

THE SCHOOL DISTRICT OF PHILADELPHIA

THE SCHOOL DISTRICT OF PHILADELPHIA No. 009 THE SCHOOL DISTRICT OF PHILADELPHIA SECTION: TITLE: SCHOOL REFORM COMMISSION OPERATIONS OVERSIGHT ADOPTED: October 5, 2011 REVISED: 009. OPERATIONS OVERSIGHT Section 1. Purpose SC 696 Pol. 003

More information

EudraVigilance stakeholder change management plan

EudraVigilance stakeholder change management plan 26 October 2015 EMA/797114/2014 Information Management Division Consultation of Project Maintenance Group 1 15 July 2015 Consultation of Eudravigilance Expert Working Group 23 September 2015 Consultation

More information

Gap Analysis of the Change Control Process The History of a Transformed Change Control System

Gap Analysis of the Change Control Process The History of a Transformed Change Control System Gap Analysis of the Change Control Process The History of a Transformed Change Control System Juan Alcazar Quality Systems Carolina, PR Content Introduction Gap Analysis Phases to perform a Gap Analysis

More information

Data Governance Planning PDA 12 May 2015

Data Governance Planning PDA 12 May 2015 Data Governance Planning PDA 12 May 2015 1 Agenda Overview of Data Integrity Assurance of Data Data Governance The Data Governance Plan Questions 2 Overview of Data Integrity 3 Data Information derived

More information

Report to the European Commission on Pharmacovigilance audits carried out in the Medicines Evaluation Board, The Netherlands period of time from

Report to the European Commission on Pharmacovigilance audits carried out in the Medicines Evaluation Board, The Netherlands period of time from Report to the European Commission on Pharmacovigilance audits carried out in the Medicines Evaluation Board, The Netherlands period of time from September 2013 to September 2015 1. INTRODUCTION Applicable

More information

Marie-Claire Rickard, GCP & Governance Manager Rachel Fay, GCP & Governance Manager Elizabeth Clough, R&D Operations Manager

Marie-Claire Rickard, GCP & Governance Manager Rachel Fay, GCP & Governance Manager Elizabeth Clough, R&D Operations Manager Standard Operating Procedures (SOP) for: Monitoring SOP 28 Version 7.0 Number: Number: Effective Date: 29 th November 2015 Review Date: 6 th January 2017 Author: Reviewer: Reviewer: Authorisation: Name

More information

QUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH

QUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH QUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH Martin Valania, Executive Director, Corporate QA and Compliance Introduction Pharmaceutical companies recognize the benefits of carefully managing

More information

Discussion Paper on the Validation of Pharmacovigilance Software provided via SaaS

Discussion Paper on the Validation of Pharmacovigilance Software provided via SaaS Discussion Paper on the Validation of Pharmacovigilance Software provided via SaaS June 2012 K Edmonds Page 1 of 10 Page 2 of 10 Contents 1. Introduction... 4 2. Quality Statement ISO 9001:2008... 4 3.

More information

Barnett International and CHI's Inaugural Clinical Trial Oversight Summit June 4-7, 2012 Omni Parker House Boston, MA

Barnett International and CHI's Inaugural Clinical Trial Oversight Summit June 4-7, 2012 Omni Parker House Boston, MA Barnett International and CHI's Inaugural Clinical Trial Oversight Summit June 4-7, 2012 Omni Parker House Boston, MA This presentation is the property of DynPort Vaccine Company LLC, a CSC company, and

More information

Comparison of EU-Pharmacovigilance System Master File (PSMF) with US System

Comparison of EU-Pharmacovigilance System Master File (PSMF) with US System Comparison of EU-Pharmacovigilance System Master File (PSMF) with US System Wissenschaftliche Prüfungsarbeit Zur Eralngung des Titels Master of Drug Regulatory Affairs der Mathematisch-Naturwissenschaftlichen

More information

ISO 9000 Introduction and Support Package: Guidance on the Documentation Requirements of ISO 9001:2008

ISO 9000 Introduction and Support Package: Guidance on the Documentation Requirements of ISO 9001:2008 Document: ISO/TC 176/SC 2/N 525R2 ISO 9000 Introduction and Support Package: 1 Introduction Two of the most important objectives in the revision of the ISO 9000 series of standards have been a) to develop

More information

Services Providers. Ivan Soto

Services Providers. Ivan Soto SOP s for Managing Application Services Providers Ivan Soto Learning Objectives At the end of this session we will have covered: Types of Managed Services Outsourcing process Quality expectations for Managed

More information

The role, duties and responsibilities of clinical trials personnel Monitoring: rules and recommendations

The role, duties and responsibilities of clinical trials personnel Monitoring: rules and recommendations The role, duties and responsibilities of clinical trials personnel Monitoring: rules and recommendations Maria Luisa Paoloni OPBG Clinical & Research Services Monitoring and Responsible of monitoring:

More information

Workshop on Quality Risk Management Making Trials Fit for Purpose

Workshop on Quality Risk Management Making Trials Fit for Purpose Clinical Trials Transformation Initiative Workshop on Quality Risk Management Making Trials Fit for Purpose Andy Lee SVP, Global Clinical Operations, Genzyme Corporation August 23/24, 2011 Hyatt Regency,

More information

Medical Information and Pharmacovigilance through acquisition. Lisa Hughes Medical Affairs Manager Actavis UK Ltd

Medical Information and Pharmacovigilance through acquisition. Lisa Hughes Medical Affairs Manager Actavis UK Ltd Medical Information and Pharmacovigilance through acquisition Lisa Hughes Medical Affairs Manager Actavis UK Ltd Disclaimer The views and opinions expressed in the following presentation are those of the

More information

Questions & answers on signal management

Questions & answers on signal management 23 October 2015 EMA/261758/2013 Inspections and Human Medicines Pharmacovigilance Division This document addresses a number of questions which stakeholders, in particular marketing authorisation holders

More information

Data Management Unit Research Institute for Health Sciences, Chiang Mai University

Data Management Unit Research Institute for Health Sciences, Chiang Mai University Data Management Unit Research Institute for Health Sciences, Chiang Mai University Clinical Data Management is the process of handling data from clinical trials. The inherent goal of any clinical data

More information

Stakeholder Meeting, 7 th June 2013 An inspector s perspective considerations for patient support and reimbursement programmes

Stakeholder Meeting, 7 th June 2013 An inspector s perspective considerations for patient support and reimbursement programmes Stakeholder Meeting, 7 th June 2013 An inspector s perspective considerations for patient support and reimbursement programmes Dr Anya Sookoo, Expert Inspector, Inspections, Enforcement & Standards Division,

More information

Guidance notes. for Patient Safety and Pharmacovigilance in Patient Support Programmes

Guidance notes. for Patient Safety and Pharmacovigilance in Patient Support Programmes Guidance notes for Patient Safety and Pharmacovigilance in Patient Support Programmes 9 May 2011 Approval Status Authors The ABPI Pharmacovigilance Expert Network Change History N/A Approval Date 9 May

More information

From paper to electronic data

From paper to electronic data From paper to electronic data Bioindustrypark, October 10, 2013 Dr Alessandra Grande Ivrea GxP Test Facility QA Manager, Head Global BMT QA Research & Development Quality Assurance MerckSerono RBM Outline

More information

4Sight Calibration Management Software

4Sight Calibration Management Software GE Measurement & Control Solutions 4Sight Calibration Management Software 4Sight calibration and maintenance management software provides visibility to the assets, data, and resources that affect maintenance,

More information

Agence fédérale des médicaments et des produits de santé

Agence fédérale des médicaments et des produits de santé Agence fédérale des médicaments et des produits de santé From Risk Management Plan to Risk Minimization Activities New Royal Decree: Status and General Explanation Role of the Pharmacovigilance Department

More information

DAIDS Bethesda, MD USA. POLICY Requirements for Clinical Quality Management Plans

DAIDS Bethesda, MD USA. POLICY Requirements for Clinical Quality Management Plans CHANGE SUMMARY: This policy and associated appendices have been reviewed for accuracy and updated to meet 508 compliance guidelines. Key changes to the policy require all sites to submit a bi-annual Clinical

More information

Accenture Accelerated R&D Services:

Accenture Accelerated R&D Services: Accenture Life Sciences Rethink Reshape Restructure for better patient outcomes Accenture Accelerated R&D Services: Pharmacovigilance Services Overview At our company, we are focused on improving lives

More information

Implementing an ISO 9001 Quality Management System

Implementing an ISO 9001 Quality Management System Implementing an ISO 9001 Quality Management System ETI Group This guide to implementing an ISO 9001 Quality Management System (QMS) was prepared by ETI Group. The guide is based on our experiences assisting

More information

The EMA current activities towards ISO IDMP implementation

The EMA current activities towards ISO IDMP implementation The EMA current activities towards ISO IDMP implementation An overview Ginas meeting 11 June 2014 Presented by: Ilaria Del Seppia, B-BD-DCM EMA An agency of the European Union Outlines EMA Vision: Objectives

More information

PHARMACEUTICAL QUALITY SYSTEM Q10

PHARMACEUTICAL QUALITY SYSTEM Q10 INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE PHARMACEUTICAL QUALITY SYSTEM Q10 Current Step

More information

U.S. Food and Drug Administration

U.S. Food and Drug Administration U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA s website for reference purposes only. It was current when produced, but is no longer maintained

More information

340B University Page 1 340B Manager and Coordinator Job Description Template

340B University Page 1 340B Manager and Coordinator Job Description Template 340B University Page 1 Purpose: The purpose of this tool is to provide a list of activities commonly assigned to the role of 340B Manager or Coordinator. This list is not exhaustive, rather a compilation

More information

ICH guideline Q10 on pharmaceutical quality system

ICH guideline Q10 on pharmaceutical quality system September 2015 EMA/CHMP/ICH/214732/2007 Committee for Human Medicinal Products Step 5 Transmission to CHMP May 2007 Transmission to interested parties May 2007 Deadline for comments November 2007 Final

More information

The Paperless QMS March 2012

The Paperless QMS March 2012 The Paperless QMS March 2012 Overview Introductions What do we mean by Paperless QMS? Short history of the (pharma) Paperless QMS What do you need your Paperless QMS to do? Practical application and considerations

More information

CLINICAL DATA MONITORING PLAN (CDMoP) PROTOCOL # [0000] [TITLE]

CLINICAL DATA MONITORING PLAN (CDMoP) PROTOCOL # [0000] [TITLE] CLINICAL DATA MONITORING PLAN (CDMoP) PROTOCOL # [0000] [TITLE] CONTRACT RESEARCH ORGANIZATION SPONSOR [NAME] [ADDRESS] 1 TABLE OF CONTENTS 1. Purpose 3 2. References 3 3. Study Roles and Responsibilities

More information

UNIVERSITY OF LEICESTER, UNIVERSITY OF LOUGHBOROUGH & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH & DEVELOPMENT SUPPORT OFFICE

UNIVERSITY OF LEICESTER, UNIVERSITY OF LOUGHBOROUGH & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH & DEVELOPMENT SUPPORT OFFICE UNIVERSITY OF LEICESTER, UNIVERSITY OF LOUGHBOROUGH & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH & DEVELOPMENT SUPPORT OFFICE STANDARD OPERATING PROCEDURES University of Leicester (UoL)

More information

Aligning Quality Management Processes to Compliance Goals

Aligning Quality Management Processes to Compliance Goals Aligning Quality Management Processes to Compliance Goals MetricStream.com Smart Consulting Group Joint Webinar February 23 rd 2012 Nigel J. Smart, Ph.D. Smart Consulting Group 20 E. Market Street West

More information

Risk based monitoring using integrated clinical development platform

Risk based monitoring using integrated clinical development platform Risk based monitoring using integrated clinical development platform Authors Sita Rama Swamy Peddiboyina Dr. Shailesh Vijay Joshi 1 Abstract Post FDA s final guidance on Risk Based Monitoring, Industry

More information

Guidance for Industry. Q10 Pharmaceutical Quality System

Guidance for Industry. Q10 Pharmaceutical Quality System Guidance for Industry Q10 Pharmaceutical Quality System U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation

More information

GCP - Records Managers Association

GCP - Records Managers Association GCP - Records Managers Association Guidance on the Scanning and Destruction of Paper Records 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 The introduction

More information

Implementation strategy for ISO IDMP in EU

Implementation strategy for ISO IDMP in EU Implementation strategy for ISO IDMP in EU Paolo Alcini Head of Data Standardisation and Analytics Business Data & Analytics Information Management EMA An agency of the European Union The EU ISO IDMP Task

More information

Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency

Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency 28 August 2015 EMA/386784/2015 Inspections and Human Medicines Pharmacovigilance Division Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the

More information

Camber Quality Assurance (QA) Approach

Camber Quality Assurance (QA) Approach Camber Quality Assurance (QA) Approach Camber s QA approach brings a tested, systematic methodology, ensuring that our customers receive the highest quality products and services, delivered via efficient

More information

PHARMACOVIGILANCE IN A BOX

PHARMACOVIGILANCE IN A BOX PHARMACOVIGILANCE IN A BOX Evolution of Pharmacovigilance Over the years the role of Pharmacovigilance or Product Vigilance (PV) has changed from capturing and reporting adverse events to a business imperative

More information

Report to the European Commission on Pharmacovigilance audits carried out in the Medicines Evaluation Board, The Netherlands period of time from July

Report to the European Commission on Pharmacovigilance audits carried out in the Medicines Evaluation Board, The Netherlands period of time from July Report to the European Commission on Pharmacovigilance audits carried out in the Medicines Evaluation Board, The Netherlands period of time from July 2012 to September 2013 1. INTRODUCTION Applicable legislation:

More information

Managing & Validating Research Data

Managing & Validating Research Data Research Management Standard Operating Procedure ISOP-H02 VERSION / REVISION: 2.0 EFFECTIVE DATE: 01 03 12 REVIEW DATE: 01 03 14 AUTHOR(S): CONTROLLER(S): APPROVED BY: Information Officer; NBT Clinical

More information

GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group dpifat@bcg-usa.com

GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group dpifat@bcg-usa.com GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group dpifat@bcg-usa.com Common Misconception Good Laboratory Practices 1) A quality system concerned with the organizational process

More information

Standard Operating Procedures (SOP) for: Reporting of Serious Breaches of GCP or the Trial Protocol sponsored CTIMP s. Lisa Austin, Research Manager

Standard Operating Procedures (SOP) for: Reporting of Serious Breaches of GCP or the Trial Protocol sponsored CTIMP s. Lisa Austin, Research Manager Standard Operating Procedures (SOP) for: Reporting of Serious Breaches of GCP or the Trial Protocol sponsored CTIMP s Author: Lisa Austin, Research Manager Purpose and Objective: To identify and standardise

More information

LIBRARY GUIDE: Clinical Medical Device

LIBRARY GUIDE: Clinical Medical Device LIBRARY GUIDE: Clinical Medical Device Table of Contents Overview... 3 Clinical Curriculum Core Program Course Descriptions: A Tour of Health Canada (PHDV89)...5 A Tour of Health Europe (PHDV90)...5 A

More information

No. 706. Page 1 of 5. Issue Date 4/21/2014

No. 706. Page 1 of 5. Issue Date 4/21/2014 Subject: ROUTINE MONITORING VISITS Standard Operating Procedure Prepared By: Beaumont Research Coordinating Center, Research Institute PURPOSE Prior Issue Date 8/15/2011 No. 706 Issue Date 4/21/2014 Page

More information

ComplianceSP TM on SharePoint. Complete Document & Process Management for Life Sciences on SharePoint 2010 & 2013

ComplianceSP TM on SharePoint. Complete Document & Process Management for Life Sciences on SharePoint 2010 & 2013 TM ComplianceSP TM on SharePoint Complete Document & Process Management for Life Sciences on SharePoint 2010 & 2013 Overview With increasing pressure on costs and margins across Life Sciences, the industry

More information

EMA Clinical Laboratory Guidance - Key points and Clarifications PAUL STEWART

EMA Clinical Laboratory Guidance - Key points and Clarifications PAUL STEWART EMA Clinical Laboratory Guidance - Key points and Clarifications PAUL STEWART Framework Labs generate data that are used to make decisions on the safety and efficacy of medicinal products; consequently,

More information

COMMUNICATIONS MANAGEMENT PLAN <PROJECT NAME>

COMMUNICATIONS MANAGEMENT PLAN <PROJECT NAME> COMMUNICATIONS MANAGEMENT PLAN TEMPLATE This Project Communications Management Template is free for you to copy and use on your project and within your organization. We hope that you find this template

More information

THE ACTIVITIES AND FUTURE DEVELOPMENT OF GCP INSPECTIONS IN TANZANIA

THE ACTIVITIES AND FUTURE DEVELOPMENT OF GCP INSPECTIONS IN TANZANIA THE ACTIVITIES AND FUTURE DEVELOPMENT OF GCP INSPECTIONS IN TANZANIA Godwin D. Ndossi, PhD Chairman Tanzania National Health Research Forum Formerly, Managing Director Tanzania Food and Nutrition Centre

More information

Establishment of a Quality Systems approach to Clinical Site Management An Overview of Standard Operating Procedures (SOPs)

Establishment of a Quality Systems approach to Clinical Site Management An Overview of Standard Operating Procedures (SOPs) Establishment of a Quality Systems approach to Clinical Site Management An Overview of Standard Operating Procedures (SOPs) Cornelia Kamp, MBA Executive Director Strategic Initiatives Tim Hackett Director

More information

What changes will ISO 9001:2015 bring?

What changes will ISO 9001:2015 bring? What changes will ISO 9001:2015 bring? 1 Introduction This presentation will cover the following topics: The ISO 9001 Revision Process Key Inputs to ISO 9001:2015 The High Level Structure Key Changes in

More information

What is the correct title of this publication? What is the current status of understanding and implementation?

What is the correct title of this publication? What is the current status of understanding and implementation? GMP Rules and Guidelines in 2013 for Computer System Validation / Computerises Systems / Electronic Records and Signatures/ IT Infrastructure and Application Compliance: What is the correct title of this

More information

Study Start-Up SS-204.01. STANDARD OPERATING PROCEDURE FOR Site Initiation Visit (SIV)

Study Start-Up SS-204.01. STANDARD OPERATING PROCEDURE FOR Site Initiation Visit (SIV) Study Start-Up SS-204.01 STANDARD OPERATING PROCEDURE FOR Site Initiation Visit (SIV) Approval: Nancy Paris, MS, FACHE President and CEO 08 March 2012 (Signature and Date) Approval: Frederick M. Schnell,

More information

Health Care Job Information Sheet #20. Clinical Research

Health Care Job Information Sheet #20. Clinical Research Health Care Job Information Sheet #20 Clinical Research A. Background B. Occupations 1) Clinical Research Associate (Study Monitor) 2) Clinical Research Coordinator 3) Other positions in the field C. Labour

More information

ORACLE CONSULTING GROUP

ORACLE CONSULTING GROUP ORACLE CONSULTING GROUP 9 Golder Ranch Rd., Ste. 1 Tucson, Arizona 9 Web Site: E-mail: 20-2-0 20-2-0 (FAX) CONSULTING MEMORANDUM QUALITY SYSTEM INSPECTION TECHNIQUE

More information

How Industry Can Partner with FDA in Defining a Risk- Based Monitoring Program

How Industry Can Partner with FDA in Defining a Risk- Based Monitoring Program How Industry Can Partner with FDA in Defining a Risk- Based Monitoring Program Presenter: Jan Holladay Pierre, MPH Quality Principal Leader DynPort Vaccine Company LLC, A CSC Company This presentation

More information

One-year report on human medicines pharmacovigilance tasks of the European Medicines Agency

One-year report on human medicines pharmacovigilance tasks of the European Medicines Agency 8 April 2014 EMA/171322/2014 Pharmacovigilance Department One-year report on human medicines pharmacovigilance tasks of the European Medicines Agency Reporting period: 2 July 2012 to 1 July 2013 7 Westferry

More information

Empowering the Quality and Regulatory Compliance Functions

Empowering the Quality and Regulatory Compliance Functions Empowering the Quality and Regulatory Compliance Functions Management must take steps to ensure that regulatory and quality compliance is everyone s responsibility. By: J. Glenn George, Kenneth Imler,

More information

REGULATORY REQUIREMENTS OF PHARMACOVIGILANCE SYSTEM AND ITS COMPARISON IN INDIA AND USA

REGULATORY REQUIREMENTS OF PHARMACOVIGILANCE SYSTEM AND ITS COMPARISON IN INDIA AND USA ISSN: 2230-7346 Krupa C. Thula et al. / JGTPS / 6(1)-(2015) 2351 2356 (Review Article) Journal of Global Trends in Pharmaceutical Sciences Journal home page: www.jgtps.com REGULATORY REQUIREMENTS OF PHARMACOVIGILANCE

More information

II. Compliance Examinations - Compliance Management System. Compliance Management System. Introduction. Board of Directors and Management Oversight

II. Compliance Examinations - Compliance Management System. Compliance Management System. Introduction. Board of Directors and Management Oversight Compliance Management System Introduction Financial institutions operate in a dynamic environment influenced by industry consolidation, convergence of financial services, emerging technology, and market

More information

CLINICAL RESEARCH GENERIC TASK DESCRIPTIONS

CLINICAL RESEARCH GENERIC TASK DESCRIPTIONS Purpose Purpose Purpose Primary responsibility for implementation, coordination, evaluation, communication and/or management of research studies. May involve more than one study or multiple sites within

More information

Camar Aircraft Products Co. QUALITY MANUAL Revision D

Camar Aircraft Products Co. QUALITY MANUAL Revision D QUALITY MANUAL Revision D Gujll'y Manual Introduction The purpose of this manual is to describe the Quality Assurance Program implemented by Camar Aircraft Products Co. (hereafter referred to as C.A.P.C.)

More information

Task Manager. Task Management

Task Manager. Task Management Task Management ibpms Business Process Applications (BPAs) are the innovative, new class of Service Oriented Business Applications (SOBAs) that help businesses automate and simplify the management of missioncritical,

More information

COMMUNIQUE. Information Technology (IT) Governance Guidance

COMMUNIQUE. Information Technology (IT) Governance Guidance COMMUNIQUE 14-COM-002 July 14, 2014 Information Technology (IT) Governance Guidance The Credit Union Prudential Supervisors Association (CUPSA) has established an IT Risk Working Group to focus on IT governance

More information

Risk Management Plan - Bayer Experience :

Risk Management Plan - Bayer Experience : Risk Management Plan - Bayer Experience : Organization & Processes Najoua ADYEL Pharmacovigilance Country Head Maghreb Introduction: Pharmacovigilance toward maturity 50 s and 60 s: from nothing to reacting

More information

New Guidelines on Good Distribution Practice of Medicinal Products for Human Use (2013/C 68/01)

New Guidelines on Good Distribution Practice of Medicinal Products for Human Use (2013/C 68/01) Safeguarding public health New Guidelines on Good Distribution Practice of Medicinal Products for Human Use (2013/C 68/01) Tony Orme, Senior GDP Inspector Inspection, Enforcement and Standards Division

More information

QUALITY MANAGEMENT SYSTEM REQUIREMENTS General Requirements. Documentation Requirements. General. Quality Manual. Control of Documents

QUALITY MANAGEMENT SYSTEM REQUIREMENTS General Requirements. Documentation Requirements. General. Quality Manual. Control of Documents Chapter j 38 Self Assessment 729 QUALITY MANAGEMENT SYSTEM REQUIREMENTS General Requirements 1. Establishing and implementing a documented quality management system 2. Implementing a documented quality

More information

Quality Agreements: Contractual Commitments by CROs to Deliver High-Quality Work

Quality Agreements: Contractual Commitments by CROs to Deliver High-Quality Work Vol. 10, No. 11, November 2014 Happy Trials to You Quality Agreements: Contractual Commitments by CROs to Deliver High-Quality Work By Tom McGrady and Susan Callery-D Amico Introduction Regulated companies

More information

Managing quality in clinical trials is the focus of daily activities that,

Managing quality in clinical trials is the focus of daily activities that, This article describes a targeted review of a quality management system that provides the organization with the inherent ability to identify, analyze, and address possible performance issues through the

More information

EphMRA Adverse Event Reporting Guidelines 2015

EphMRA Adverse Event Reporting Guidelines 2015 EphMRA Adverse Event Reporting Guidelines 2015 Based upon the Guideline on good pharmacovigilance practices (GVP) Module VI Management and reporting of adverse reactions to medicinal products European

More information

WE ANSWER QUESTIONS THAT NO ONE ELSE CAN. 68 T.W. Alexander Dr. P.O. Box 13628 Research Triangle Park, NC 27709 www.cuttingedgeinfo.

WE ANSWER QUESTIONS THAT NO ONE ELSE CAN. 68 T.W. Alexander Dr. P.O. Box 13628 Research Triangle Park, NC 27709 www.cuttingedgeinfo. MEDICAL INFORMATION AND CALL CENTER PERFORMANCE BUILDING NEW PRACTICES TO MEET THE EVOLVING NEEDS OF HCPS AND PATIENTS FULL TABLE OF CONTENTS & CHARTS AND GRAPHICS 68 T.W. Alexander Dr. P.O. Box 13628

More information

Quality Management in Clinical Trials

Quality Management in Clinical Trials CLINICAL CASE STUDY SERIES Quality Management in Clinical Trials Clinical trials are conducted to collect the data necessary to provide information for academia, industry, and regulators to make decisions

More information

Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions

Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions WELCOME Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions Contents: Introduction GMP Audit GMP Audit plan GMP Auditing

More information

Validation Consultant

Validation Consultant Personal Data Name Title Validation Consultant Contact jsb-validierung Zwischen den Bächen 9 D 79618 Rheinfelden Tel: +49 7623 79 49 82 Mobile: +49 172 737 84 86 E-Mail: Internet: jsb-val@online.de http://www.jsb-validierung.de

More information

WHITEPAPER: SOFTWARE APPS AS MEDICAL DEVICES THE REGULATORY LANDSCAPE

WHITEPAPER: SOFTWARE APPS AS MEDICAL DEVICES THE REGULATORY LANDSCAPE WHITEPAPER: SOFTWARE APPS AS MEDICAL DEVICES THE REGULATORY LANDSCAPE White paper produced by Maetrics For more information, please contact global sales +1 610 458 9312 +1 877 623 8742 globalsales@maetrics.com

More information

Guidance notes on the management of adverse events and product complaints from digital media

Guidance notes on the management of adverse events and product complaints from digital media Guidance notes on the management of adverse events and product complaints from digital media Guidance notes on the management of adverse events and product complaints from digital media ABPI Pharmacovigilance

More information

FINANCIAL ASSESSMENT CRITERIA (The Assessment Criteria should be read in conjunction with OSFI s Supervisory Framework)

FINANCIAL ASSESSMENT CRITERIA (The Assessment Criteria should be read in conjunction with OSFI s Supervisory Framework) ROLE OF Financial is an independent function responsible for ensuring the timely and accurate reporting and in-depth analysis of the operational results of the operating units (including business lines)

More information

Good practice guide on recording, coding, reporting and assessment of medication errors

Good practice guide on recording, coding, reporting and assessment of medication errors 1 2 3 14 April 2015 EMA/762563/2014 Pharmacovigilance Risk Assessment Committee (PRAC) 4 5 6 Good practice guide on recording, coding, reporting and assessment of medication errors Draft Draft finalised

More information

Central Project Office: Charter

Central Project Office: Charter Central Project Office: Charter ITCS: Central Project Office EAST CAROLINA UNIVERSITY 209 COTANCHE STREET, GREENVILLE, NC 27858 1 Table of Contents INTRODUCTION... 3 PURPOSE... 3 EXPECTED BENEFITS... 3

More information

ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION

ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 038-1 26 March 2012 AIDE-MEMOIRE ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION PIC/S March 2012 Reproduction

More information

Pharmaceutical Quality & Clinical Research Quality: The Interaction

Pharmaceutical Quality & Clinical Research Quality: The Interaction 4 th Jerusalem Conference: Quality by Design (QbD)) & Pharma Sciences, May 20-22, 2014 The Edmund Safra Campus, The Hebrew University of Jerusalem Pharmaceutical Quality & Clinical Research Quality: The

More information

Guideline on good pharmacovigilance practices (GVP)

Guideline on good pharmacovigilance practices (GVP) 19 April 2013 EMA/813938/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VIII Post-authorisation safety studies (Rev 1) Draft of first version finalised by the Agency in collaboration

More information

The Global Guideline for GCP Audit

The Global Guideline for GCP Audit The Global Guideline for GCP Audit Author: JSQA: Hiroyasu Yamashita, e-mail: hiroyasu-yamashita@ds-pharma.co.jp Reviewed and Acknowledged by: BARQA: Patricia Fitzgerald, e-mail: Patricia.fitzgerald@adamas.co.uk

More information

Data & Analytics in Internal Audit. January 13, 2015

Data & Analytics in Internal Audit. January 13, 2015 Data & Analytics in Internal Audit January 13, 2015 With You Today KPMG Brian Greenberg, Director, Data & Analytics-enabled Internal Audit (National) Sean Mulyanto, Manager IT Advisory (Los Angeles) 1

More information

Competentes en Medicamentos

Competentes en Medicamentos VIII Encuentro de Autoridades Competentes en Medicamentos de los Países Iberoamericanos (EAMI) 12-14 de Mayo 2010 Madrid MARTIN TERBERGER Jefe de la Unidad de Productos Farmacéuticos Nuevas iniciativas

More information

Medical Device Training Program 2015

Medical Device Training Program 2015 Medical Device Training Introduction Supplementary training and education is often overlooked by medical device professionals until it is triggered by an upcoming FDA or Notified Body and/or ISO 13485

More information

APPENDIX 50. Enterprise risk management - Risk management overview

APPENDIX 50. Enterprise risk management - Risk management overview APPENDIX 50 Enterprise risk management - Risk management overview Energex regulatory proposal October 2014 ENTERPRISE RISK MANAGEMENT Risk Management Overview (RMO) 06 11 2013 Table of Contents 1. INTRODUCTION...

More information

Data submission of authorised medicines in the European Union

Data submission of authorised medicines in the European Union 23 February 2015 EMA/471367/2014, Rev. 1 1 Business Data and Support Department Data submission of authorised medicines in the European Union Outlines on Article 57(2) of Regulation (EC) No 726/2004 1

More information

Cloud Vendor Evaluation

Cloud Vendor Evaluation Cloud Vendor Evaluation Checklist Life Sciences in the Cloud Cloud Vendor Evaluation Checklist What to evaluate when choosing a cloud vendor in Life Sciences Cloud computing is radically changing business

More information

Internal Audit Strategic and Annual Plans 2015/16

Internal Audit Strategic and Annual Plans 2015/16 Internal Audit Strategic and Annual Plans 2015/16 Financial Scrutiny and Audit Committee 10 February 2015 Agenda Item No 8 Summary: This report provides an overview of the stages followed prior to the

More information